Factors | Univariate | Multivariate | |||
---|---|---|---|---|---|
P value | HR | 95%CI | P value | ||
Gender(M/F) | 0.686 | Â | Â | Â | |
Age(≤60/>60y) | 0.716 |  |  |  | |
Tumor type (naive/recurrent) | 0.088 | – | – | – | |
Etiology (Hepatitis/others) | 0.508 | Â | Â | Â | |
Type (Naïve/recurrent) | 0.563 |  |  |  | |
Surgery history of liver (Y/N) | 0.566 | Â | Â | Â | |
Liver cirrhosis (Y/N) | 0.382 | Â | Â | Â | |
Antiviral treatment (Y/N) | 0.864 | Â | Â | Â | |
ECOG performance status (0/1) | 0.811 | Â | Â | Â | |
Child-Pugh (A/B) | 0.221 | Â | Â | Â | |
BCLC stage of primary HCC (A/B) | 0.231 | Â | Â | Â | |
AFP (≥400/< 400 μg/L) | 0.197 |  |  |  | |
PLT (≥100/< 100 × 109/L) | 0.374 |  |  |  | |
PT (≤14/> 14 s) | 0.221 |  |  |  | |
ALB (≤35/> 35 g/L) | 0.354 |  |  |  | |
ALT (≤40/> 40 IU/L) | 1.000 |  |  |  | |
TB (≤17.1/> 17.1 mol/L) | 0.401 |  |  |  | |
Tumor number (single /multiple) | 0.519 | Â | Â | Â | |
Location (Paracaval portion/ Caudate process/ Spiegel’s lobe) | 0.807 |  |  |  | |
Tumor size (≤2 cm/> 2 cm) | 0.907 |  |  |  | |
Puncture approach (LA/ RA/ combination approach) | 0.177 | Â | Â | Â | |
Treatment strategy | RFA/ EA/ RFA-EA | 0.055 | – | – | – |
EA/RFA or RFA-EA | 0.029 | 5.031 | 1.299–19.481 | 0.019 | |
RFA or EA/RFA-EA | 0.721 | Â | Â | Â |